TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T08885 XX ID T08885 XX DT 02.05.2006 (created); kar. CO Copyright (C), QIAGEN. XX FA Vav-isoform1 XX SY p95vav; Vav; Vav-1; Vav1. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G004620 VAV1; HGNC: VAV1. XX CL C0013; HLH-ZIP. XX SZ 845 AA; 98.3 kDa (cDNA) (calc.). XX SQ MELWRQCTHWLIQCRVLPPSHRVTWDGAQVCELAQALRDGVLLCQLLNNLLPHAINLREV SQ NLRPQMSQFLCLKNIRTFLSTCCEKFGLKRSELFEAFDLFDVQDFGKVIYTLSALSWTPI SQ AQNRGIMPFPTEEESVGDEDIYSGLSDQIDDTVEEDEDLYDCVENEEAEGDEIYEDLMRS SQ EPVSMPPKMTEYDKRCCCLREIQQTEEKYTDTLGSIQQHFLKPLQRFLKPQDIEIIFINI SQ EDLLRVHTHFLKEMKEALGTPGAANLYQVFIKYKERFLVYGRYCSQVESASKHLDRVAAA SQ REDVQMKLEECSQRANNGRFTLRDLLMVPMQRVLKYHLLLQELVKHTQEAMEKENLRLAL SQ DAMRDLAQCVNEVKRDNETLRQITNFQLSIENLDQSLAHYGRPKIDGELKITSVERRSKM SQ DRYAFLLDKALLICKRRGDSYDLKDFVNLHSFQVRDDSSGDRDNKKWSHMFLLIEDQGAQ SQ GYELFFKTRELKKKWMEQFEMAISNIYPENATANGHDFQMFSFEETTSCKACQMLLRGTF SQ YQGYRCHRCRASAHKECLGRVPPCGRHGQDFPGTMKKDKLHRRAQDKKRNELGLPKMEVF SQ QEYYGLPPPPGAIGPFLRLNPGDIVELTKAEAEQNWWEGRNTSTNEIGWFPCNRVKPYVH SQ GPPQDLSVHLWYAGPMERAGAESILANRSDGTFLVRQRVKDAAEFAISIKYNVEVKHIKI SQ MTAEGLYRITEKKAFRGLTELVEFYQQNSLKDCFKSLDTTLQFPFKEPEKRTISRPAVGS SQ TKYFGTAKARYDFCARDRSELSLKEGDIIKILNKKGQQGWWRGEIYGRVGWFPANYVEED SQ YSEYC XX SC Swiss-Prot#P15498 XX FT 1 119 PS50021; CH. FT 3 115 SM00033; ch_5. FT 3 120 PF00307; Calponin homology (CH) domain. FT 95 386 PF00478; IMP dehydrogenase / GMP reductase domain. FT 194 373 PS50010; DH_2. FT 198 372 PF00621; RhoGEF domain. FT 198 372 SM00325; RhoGEF_3. FT 402 504 PS50003; PH_DOMAIN. FT 403 504 PF00169; PH domain. FT 403 506 SM00233; PH_update. FT 515 564 PS50081; ZF_DAG_PE_2. FT 516 564 SM00109; c1_12. FT 516 568 PF00130; Phorbol esters/diacylglycerol binding domain. FT 595 659 SM00326; SH3_2. FT 596 658 PF07653; Variant SH3 domain. FT 617 660 PS50002; SH3. FT 669 752 SM00252; SH2_5. FT 671 746 PF00017; SH2 domain. FT 671 766 PS50001; SH2. FT 783 843 PS50002; SH3. FT 786 841 PF00018; SH3 domain. FT 786 842 SM00326; SH3_2. XX IN T05110 Ku70; human, Homo sapiens. XX DR TRANSPATH: MO000080894. DR EMBL: AF030227; DR EMBL: M59834; HSVAVPO1. DR EMBL: X16316; HSVAVPO. DR UniProtKB: P15498; XX RN [1]; RE0017781. RX PUBMED: 11287617. RA Kaminuma O., Deckert M., Elly C., Liu Y. C., Altman A. RT Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter. RL Mol. Cell. Biol. 21:3126-3136 (2001). RN [2]; RE0047691. RX PUBMED: 8524317. RA Romero F., Dargemont C., Pozo F., Reeves W. H., Camonis J., Gisselbrecht S., Fischer S. RT p95vav associates with the nuclear protein Ku-70. RL Mol. Cell. Biol. 16:37-44 (1996). RN [3]; RE0047722. RX PUBMED: 9488731. RA Romero F., Germani A., Puvion E., Camonis J., Varin-Blank N., Gisselbrecht S., Fischer S. RT Vav binding to heterogeneous nuclear ribonucleoprotein (hnRNP) C. Evidence for Vav-hnRNP interactions in an RNA-dependent manner. RL J. Biol. Chem. 273:5923-5931 (1998). RN [4]; RE0049465. RX PUBMED: 16273093. RA Jones R. B., Gordus A., Krall J. A., MacBeath G. RT A quantitative protein interaction network for the ErbB receptors using protein microarrays. RL Nature 439:168-174 (2006). RN [5]; RE0066822. RX PUBMED: 15388330. RA Shim E. K., Moon C. S., Lee G. Y., Ha Y. J., Chae S. K., Lee J. R. RT Association of the Src homology 2 domain-containing leukocyte phosphoprotein of 76 kD (SLP-76) with the p85 subunit of phosphoinositide 3-kinase. RL FEBS Lett. 575:35-40 (2004). RN [6]; RE0067521. RX PUBMED: 17050525. RA Miletic A. V., Sakata-Sogawa K., Hiroshima M., Hamann M. J., Gomez T. S., Ota N., Kloeppel T., Kanagawa O., Tokunaga M., Billadeau D. D., Swat W. RT Vav1 acidic region tyrosine 174 is required for the formation of T cell receptor-induced microclusters and is essential in T cell development and activation. RL J. Biol. Chem. 281:38257-38265 (2006). XX //